The chronic degeneration of motor neurons and muscle weakness seen in ALS patients can be modeled in transgenic mice harboring the human superoxide dismutase 1 (SOD1) mutation (G93A). This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.